PerkinElmer,
Inc. (NYSE: PKI), a global leader focused on improving the health
and safety of people and their environment, today announced the
appointment of Frank A. "Andy” Wilson as senior vice president, chief
financial officer, and chief accounting officer for the Company. In this
role, Wilson will have overall leadership responsibility for the
strategy and operations for all of the Company’s finance and control
functions. He will assume his new role on May 18.
"Andy brings to PerkinElmer over 20 years of expertise in developing
effective financial and business strategies for driving financial
performance,” commented Robert Friel, the Company’s chairman and CEO.
"His experience in the medical and environmental industries combined
with his strong strategic skills and general management experience will
be a significant asset to PerkinElmer.”
Prior to joining PerkinElmer, Wilson was the corporate vice president of
investor relations at Danaher
Corporation, a leading manufacturer of professional instrumentation,
medical and industrial technologies and tools and components. While at
Danaher, he held key financial and business management roles. Wilson
joined Danaher in 1997, after several years with AlliedSignal,
Inc. (now Honeywell International, Inc.) where he served as chief
financial officer for one of its businesses. His prior experience
includes five years with PepsiCo
Inc. in financial leadership and controllership positions and five
years with KPMG
Peat Marwick.
Wilson received his Bachelors Degree in accounting from Baylor
University and is a certified public accountant.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
approximately $2 billion in 2008, has around 8,500 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through www.perkinelmer.com
or 1-877-PKI-NYSE.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, but not limited to, statements relating to estimates and
projections of future earnings per share, cash flow and revenue growth
and other financial results, developments relating to our customers and
end-markets, and plans concerning business development opportunities.
Words such as "believes," "intends," "anticipates," "plans," "expects,"
"projects," "forecasts," "will" and similar expressions, and references
to guidance, are intended to identify forward-looking statements. Such
statements are based on management's current assumptions and
expectations and no assurances can be given that our assumptions or
expectations will prove to be correct. A number of important risk
factors could cause actual results to differ materially from the results
described, implied or projected in any forward-looking statements. These
factors include, without limitation: (1) markets into which we sell our
products decline or do not grow as anticipated; (2) global economic,
political and other risks; (3) our failure to introduce new products in
a timely manner; (4) our ability to execute acquisitions and license
technologies, or to successfully integrate acquired businesses and
licensed technologies into our existing business or to make them
profitable; (5) our failure to adequately protect our intellectual
property; (6) the loss of any of our licenses or licensed rights; (7)
our ability to compete effectively; (8) fluctuation in our quarterly
operating results and our ability to adjust our operations to address
unexpected changes; (9) significant disruption in third-party package
delivery and import/export services or significant increases in prices
for those services; (10) disruptions in the supply of raw materials, key
components and supplies; (11) the manufacture and sale of products may
expose us to product liability claims; (12) our failure to maintain
compliance with applicable government regulations; (13) regulatory
changes; (14) our failure to comply with health care industry
regulations; (15) economic, political and other risks associated with
foreign operations; (16) our ability to retain key personnel; (17)
significant disruption in our information technology systems or the
failure to successfully implement new systems; (18) restrictions in our
credit agreements; (19) our ability to realize the full value of our
intangible assets; (20) significant fluctuations in our stock price;
(21) dividends we pay on our stock could be reduced or eliminated in the
future; and (22) other factors which we describe under the caption "Risk
Factors" in our most recent annual report on Form 10-K and in our other
filings with the Securities and Exchange Commission. We disclaim any
intention or obligation to update any forward-looking statements as a
result of developments occurring after the date of this press release.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5952198&lang=en
